Moreover, genes encoding enzymes that regulate de novo ceramide biosynthesis including SPTLC2, were also significantly overexpressed in NASH male patients (Supplemental Fig. 7). This evidence concerns the gene SPTLC2 and metabolic dysfunction-associated steatohepatitis.